Jefferies sets a new price target for McKesson Corporation (NYSE:MCK) at $900, indicating a potential increase of 16.96%.McKesson's acquisitions of PRISM Vision and Core Ventures aim to bolster its oncology, multispecialty, and technology-enabled segments.The company's Q1 FY26 results show strong revenue growth and robust cash flow guidance, supporting a raised long-term EPS target.McKesson Corporation (NYSE:MCK) is a prominent player in the healthcare sector, known for its role in distributing pharmaceutic ...